Work

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Year: 2018

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(18)30239-4

Authors: Regina Katzenschlager, Werner Poewe, Olivier Rascol, Claudia Trenkwalder, Günther Deuschl, K Ray Chaudhuri, Tove Henriksen, Teus van Laar, Kevin Spivey, Senthil Vel, Harry Staines, Andrew Lees

Institutions: Donauspital, Innsbruck Medical University, Universität Innsbruck, Inserm, Centre Hospitalier Universitaire de Toulouse, French Clinical Research Infrastructure Network, Centre d’Investigation Clinique 1436, Université de Toulouse, Universitätsmedizin Göttingen, Paracelsus Elena Klinik Kassel, Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, King's College Hospital, Bispebjerg Hospital, University Medical Center Groningen, Britannia Pharmaceuticals Ltd (United Kingdom), UCL Queen Square Institute of Neurology, University College London

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Britannia Pharmaceuticals

OpenAlex ID: W2884603783

FWCI: 23.17

Cites: 27

Cited by: 362

Related to: 10